Cogent Biosciences to Present at Jefferies Virtual Healthcare Conference 2021
News provided by
Share this article
Share this article
CAMBRIDGE, Mass. and BOULDER, Colo., May 26, 2021 /PRNewswire/ Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that Andrew Robbins, Chief Executive Officer and President, will present at Jefferies Virtual Healthcare Conference on Thursday, June 3
rd, from 11:30-11:55am ET.
Access to the webcast of this event, as well as an archived recording, will be available under the Events tab on the investor relations section of the Cogent Biosciences website at: https://investors.cogentbio.com/events.
Cogent Biosciences Announces Creation of Cogent Research Team
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Cogent Biosciences to Present at Virtual 10th Annual SVB Leerlink Global Healthcare Conference 2021
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
Cogent Biosciences to Present at LifeSci Partners Virtual Precision Oncology Day 2021
News provided by
Share this article
Share this article
CAMBRIDGE, Mass., Feb. 11, 2021 /PRNewswire/ Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that Andrew Robbins, Chief Executive Officer and President, will present a corporate overview at the LifeSci Partners Precision Oncology Day taking place virtually on February 17, 2021.
A recording of the presentation will be available to view after the conference under the Events tab on the investor relations section of the Cogent Biosciences website at: https://investors.cogentbio.com/events.